We've published updated versions of our Codes of Practice (except Code F, Part two: Deceased organ and tissue donation which was published on 1 June 2023).
Our Business Plan sets out our priorities for the business year 2023 to 2024.
The purpose of this guidance is to assist licensed establishments to meet the HTA’s licensing standards. The documents contain additional information and examples of how to meet certain Standards.
All establishments licensed to carry out activities under the Human Tissue (Quality and Safety for Human Application) Regulations 2007 must submit data relating to the activities undertaken and the tissue types worked with between 1 January and 31 December on an annual basis.
Submission of the data is a condition of your HTA licence.
Earlier this year the Minister for Innovation laid out a challenge to health regulators, the Professional Standards Authority, NICE and NHSX during an unprecedented roundtable. If the post-Brexit ambition, as outlined in the government’s Life Sciences Vision, is to provide a world-class regulatory environment that benefits patients and the public while also promoting jobs, growth, and investment, how do we collectively map out the principles and practices needed to achieve these goals? There was a high degree of commi
Today, the Human Tissue Authority (HTA) has published an updated version of Code of Practice D: Public Display. The HTA undertook a review of Code D to align the expectations of consent for imported material for public display with that of material originating in England, Wales and Northern Ireland.
A key principle of the Human Tissue Act (HT Act) is that all human bodies, body parts and tissue should be treated with appropriate respect and dignity. It is important that checks and procedures are put into place to ensure that appropriate consent is obtained for the public display of human material. In England, Wales and Northern Ireland, the law requires that the person whose body or body parts will be displayed after death must have given their consent in writing and for it to have been witnessed and attested.
Clinicians and transplant teams are responsible for the overall care of donors and recipients, and for assessing the medical suitability of potential donors. The Regulations require the clinician with responsibility for the donor to refer the matter to the HTA. As part of this referral specific information, certain assurances are required to ensure the legislative requirements are addressed.